tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

DE:SMZ1 Stock Latest News

Sino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug
Company AnnouncementsSino Biopharm Wins China Nod for New Lung Cancer Use of PD-L1 Drug
12d ago
Sino Biopharm Completes Phase III Enrollment for Next-Gen HER2-Low Breast Cancer Drug
PremiumCompany Announcements
Sino Biopharm Completes Phase III Enrollment for Next-Gen HER2-Low Breast Cancer Drug
18d ago
Sino Biopharm’s CLDN18.2 ADC Becomes First to Complete Phase III Enrollment
PremiumCompany Announcements
Sino Biopharm’s CLDN18.2 ADC Becomes First to Complete Phase III Enrollment
19d ago
Sino Biopharm’s Hepatitis B Drug TQA3605 Hits Key Goal in Phase II Trial
PremiumCompany Announcements
Sino Biopharm’s Hepatitis B Drug TQA3605 Hits Key Goal in Phase II Trial
1M ago
Sino Biopharm Buys siRNA Specialist Hygieia in RMB1.2 Billion Chronic Disease Push
PremiumCompany Announcements
Sino Biopharm Buys siRNA Specialist Hygieia in RMB1.2 Billion Chronic Disease Push
2M ago
Sino Biopharm Appoints New Company Secretary and Authorised Representative
PremiumCompany AnnouncementsSino Biopharm Appoints New Company Secretary and Authorised Representative
2M ago
Sino Biopharm Advances First-in-Class ROCK2 Inhibitor TDI01 Into Global First Phase III IPF Trial
Premium
Company Announcements
Sino Biopharm Advances First-in-Class ROCK2 Inhibitor TDI01 Into Global First Phase III IPF Trial
2M ago
Sino Biopharm’s Oral Psoriasis Drug TQH3906 Delivers Biologic-Like Efficacy in Phase II Trial
Premium
Company Announcements
Sino Biopharm’s Oral Psoriasis Drug TQH3906 Delivers Biologic-Like Efficacy in Phase II Trial
2M ago
Sino Biopharmaceutical’s Culmerciclib Capsule Gains Approval for Breast Cancer Treatment
PremiumCompany Announcements
Sino Biopharmaceutical’s Culmerciclib Capsule Gains Approval for Breast Cancer Treatment
3M ago
Sino Biopharmaceutical’s Oral GLP-1 Drug Approved for Clinical Trials
PremiumCompany Announcements
Sino Biopharmaceutical’s Oral GLP-1 Drug Approved for Clinical Trials
3M ago
Sino Biopharmaceutical’s Rotigotine Patch Gains Approval for Parkinson’s Treatment
PremiumCompany Announcements
Sino Biopharmaceutical’s Rotigotine Patch Gains Approval for Parkinson’s Treatment
3M ago
Sino Biopharmaceutical Advances Pain Management with Innovative Analgesic Trial
PremiumCompany Announcements
Sino Biopharmaceutical Advances Pain Management with Innovative Analgesic Trial
3M ago
Sino Biopharmaceutical’s LM-350 Receives Clinical Trial Approval in China
PremiumCompany AnnouncementsSino Biopharmaceutical’s LM-350 Receives Clinical Trial Approval in China
3M ago
Sino Biopharmaceutical’s Culmerciclib Shows Promising Results in Phase III Breast Cancer Study
Premium
Company Announcements
Sino Biopharmaceutical’s Culmerciclib Shows Promising Results in Phase III Breast Cancer Study
4M ago
Sino Biopharmaceutical’s TQ-B3234 Gains Breakthrough Therapy Designation
Premium
Company Announcements
Sino Biopharmaceutical’s TQ-B3234 Gains Breakthrough Therapy Designation
5M ago
Sino Biopharmaceutical’s TQB2102 Gains Breakthrough Designation in China
PremiumCompany Announcements
Sino Biopharmaceutical’s TQB2102 Gains Breakthrough Designation in China
5M ago
Sino Biopharmaceutical Advances LM-350 Clinical Trials in Australia
PremiumCompany Announcements
Sino Biopharmaceutical Advances LM-350 Clinical Trials in Australia
5M ago
Sino Biopharmaceutical Advances Innovative Cancer Therapy with Phase I Trial
PremiumCompany Announcements
Sino Biopharmaceutical Advances Innovative Cancer Therapy with Phase I Trial
5M ago
Sino Biopharmaceutical’s Innovative Diabetes Drug Gains Regulatory Acceptance
PremiumCompany Announcements
Sino Biopharmaceutical’s Innovative Diabetes Drug Gains Regulatory Acceptance
5M ago
Sino Biopharmaceutical Gains Approval for Groundbreaking Lung Cancer Drug in China
PremiumCompany AnnouncementsSino Biopharmaceutical Gains Approval for Groundbreaking Lung Cancer Drug in China
6M ago
Sino Biopharmaceutical Advances Respiratory Drug Portfolio with Promising Study Results
Premium
Company Announcements
Sino Biopharmaceutical Advances Respiratory Drug Portfolio with Promising Study Results
6M ago
Sino Biopharmaceutical’s Zongertinib Gains Breakthrough Designation in China
Premium
Company Announcements
Sino Biopharmaceutical’s Zongertinib Gains Breakthrough Designation in China
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >